Evidence map›Paper›PMID 21821284›Full record

ArticleBiomaterials2011

A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells.

Yang Liu, Xintong Wang, Dan S Kaufman, Wei Shen

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Using polymeric materials to control stem cell behavior for tissue regeneration.Birth defects research. Part C, Embryo today : reviews · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yang LiuDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Xintong Wang
Dan S Kaufman
Wei Shen
University of Minnesota · US

Funding

Midwestern Progenitor Cell ConsortiumU01HL100407 · NHLBI · UNIVERSITY OF MINNESOTA · PI GARRY, DANIEL J., KYBA, MICHAEL · 2009 to 2015
$7.8M
Hematopoietic precursor development from human ES cellsR01HL077923 · NHLBI · UNIVERSITY OF MINNESOTA · PI KAUFMAN, DAN S. · 2006 to 2010
$2.1M
NHLBI NIH HHS R01 HL077923NHLBI NIH HHS U01 HL100407
6 · The paper itself

Abstract

Our ability to guide differentiation of human pluripotent stem cells (hPSCs) toward desired lineages efficiently and reproducibly in xeno-free conditions is the key to advancing hPSC technology from the laboratory to clinical use. Here we report an engineered biomimetic substrate functionalized with both peptide ligands for α5β1 and α6β1 integrins to support efficient early mesodermal differentiation of human embryonic stem cells (hESCs) when cultured in a differentiation medium containing BMP4. In contrast, mesodermal differentiation is not induced on substrates functionalized with either ligand alone even though the culture medium is identical. Mesodermal differentiation was characterized by immunofluorescent staining, flow cytometric analysis, and RT-PCR analysis of early mesodermal markers Brachyury, Mixl1, and Wnt3. The early mesodermal progenitors derived on the substrate functionalized with both integrin ligands have the normal developmental potential to further differentiate along the hemato-endothelial and cardiac lineages. Immobilized ligands for α5β1 and α6β1 integrins both are permissive, necessary, and sufficient insoluble ligands in this engineered system to support early mesodermal differentiation of hESCs. This synthetic substrate, in conjunction with defined soluble factors, constructs a well-controlled and xeno-free early mesodermal differentiation niche that offers advantages over the previously reported niche constructed with the Matrigel-coated substrate.

Indexed as

AnimalsAntigens, CD34BiomarkersBlood CellsBrachyury ProteinCell DifferentiationCell LineageCells, CulturedCell SurvivalEmbryonic Stem CellsEndothelial CellsFetal ProteinsFlow CytometryGATA4 Transcription FactorGene Expression ProfilingGene Expression RegulationAntigens, CD34BiomarkersBrachyury ProteinFetal ProteinsGATA4 protein, humanGATA4 Transcription FactorIntegrinsLigandsMADS Domain ProteinsMEF2A protein, humanMEF2 Transcription FactorsMyogenic Regulatory FactorsPeptidesT-Box Domain Proteins

Identifiers

PMID21821284
PMCPMC3189998
OpenAlexW1968506907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.